Academic Collaborations Leverage relationships with leading research institutions and national laboratories already listed as customers to expand partnerships, offering end-to-end antibody, antigen, and biomarker panels for infectious disease, neuroscience, and cardiovascular research.

In Vitro Availability Promote the new in vitro produced antibody line to customers prioritizing ethical, scalable, or regulatory-friendly reagents, highlighting compatibility with quantitative sandwich immunoassays and rapid tests to appeal to diagnostics developers.

Biomarker Portfolio Position the broad cardiovascular, infectious disease, and tumor marker reagents as a turnkey panel solution for labs and diagnostic developers aiming to accelerate assay development, validation, and regulatory submission.

Small Biz Advantage Emphasize WBENC-certified women-owned status and ISO 9001 quality for potential government, academic, and industry buyers seeking supplier diversity and quality assurance in certified vendors.

Global Reach Highlight worldwide reagent availability and validated products for both research and clinical diagnostics to target international labs and multinational grant-funded programs seeking reliable supply chains.